LCPE:LSE:LSE-Ossiam Shiller Barclays Cape Europe Sector Value TR UCITS (GBX)

ETF | Others |

Last Closing

USD 44310

Change

+510.00 (+1.16)%

Market Cap

USD 0.16B

Volume

2.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 636.40B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 330.91B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B

ETFs Containing LCPE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.87% 46% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.87% 45% F 51% F
Trailing 12 Months  
Capital Gain 5.91% 40% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.91% 39% F 50% F
Trailing 5 Years  
Capital Gain 61.27% 71% C- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.27% 69% C- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 9.71% 71% C- 73% C
Dividend Return 9.71% 70% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.47% 66% D+ 79% B-
Risk Adjusted Return 92.78% 96% N/A 97% N/A
Market Capitalization 0.16B 52% F 45% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike